ASKG843 / Aosaikang Pharma - LARVOL DELTA

[VIRTUAL] ASKG843, a bifunctional fusion protein of PD1/TGF-βRII, demonstrates potent in vitro/in vivo activities, and excellent pharmacokinetic properties in non-human primates (NHPs) with good safety profiles (AACR 2021) - "ASKG843 demonstrated potent bi-functional activities in vitro and in vivo endowed by its design. Superior PK to the reference molecule yet maintaining better safety profiles in NHPs support further development of ASKG843 as an effective immunotherapeutic candidate."

PK/PD data • Preclinical • Oncology • PD-1 • TGFB1